PROMETHERA BIOSCIENCES
0809.788.365 · rovalta.com · 23/09/2026
PROMETHERA BIOSCIENCES
Company — Opening of bankruptcy.
Overview
What does PROMETHERA BIOSCIENCES do?
PROMETHERA BIOSCIENCES is a Public limited company incorporated in 2009. Its main activity is: Other human health activities. Its registered office is in Mont-Saint-Guibert.
1435 Mont-Saint-Guibert · WallonieSee on map
Joint committees (2)
- 200
- 218
Trend over 14 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||
| Gross margin | 55,3 k € | -99.7% | 18,1 M € | +209% | -16,6 M € | +29.9% | -23,7 M € | -57.5% | -15,1 M € | -105% | -7,3 M € | -22.4% | -6 M € | -70.5% | -3,5 M € | +1.9% | -3,6 M € | -8.0% | -3,3 M € | -40.8% | -2,4 M € | +6.3% | -2,5 M € | -101% | -1,3 M € | -133% | -536,9 k € |
| EBITDA | -500 k € | -103% | 17,7 M € | +176% | -23,3 M € | +21.8% | -29,8 M € | -56.0% | -19,1 M € | -84.2% | -10,4 M € | -19.3% | -8,7 M € | -42.4% | -6,1 M € | +1.3% | -6,2 M € | -10.5% | -5,6 M € | -35.9% | -4,1 M € | -25.2% | -3,3 M € | -101% | -1,6 M € | -204% | -537,2 k € |
| Operating result | -500 k € | -103% | 17 M € | +172% | -23,6 M € | +21.5% | -30,1 M € | -54.7% | -19,5 M € | -80.6% | -10,8 M € | -18.2% | -9,1 M € | -39.7% | -6,5 M € | +2.3% | -6,7 M € | -10.5% | -6 M € | -35.3% | -4,5 M € | -26.5% | -3,5 M € | -106% | -1,7 M € | -211% | -549,8 k € |
| Net result | -519,5 k € | -103% | 16,5 M € | +134% | -49 M € | -61.8% | -30,3 M € | -45.8% | -20,8 M € | -70.1% | -12,2 M € | -32.6% | -9,2 M € | -37.0% | -6,7 M € | -0.5% | -6,7 M € | -10.6% | -6 M € | -35.4% | -4,5 M € | -27.3% | -3,5 M € | -107% | -1,7 M € | -207% | -551,3 k € |
| Balance sheet | |||||||||||||||||||||||||||
| Equity | -1,5 M € | -53.2% | -976,5 k € | +94.4% | -17,5 M € | -156% | 31,4 M € | +35.7% | 23,2 M € | +1486% | -1,7 M € | -116% | 10,4 M € | +16.2% | 9 M € | +64.1% | 5,5 M € | -10.9% | 6,1 M € | +46.2% | 4,2 M € | +1196% | -382,9 k € | -112% | 3,1 M € | +67.6% | 1,9 M € |
| Total assets | 4,3 M € | -1.7% | 4,4 M € | -43.2% | 7,8 M € | -84.1% | 48,7 M € | +15.6% | 42,1 M € | +93.6% | 21,8 M € | -15.7% | 25,8 M € | +75.8% | 14,7 M € | +16.4% | 12,6 M € | +7.1% | 11,8 M € | +48.3% | 7,9 M € | +50.8% | 5,3 M € | -11.7% | 6 M € | +185% | 2,1 M € |
| Cash | 611 € | -78.4% | 2,8 k € | -99.9% | 2,3 M € | -78.0% | 10,4 M € | -13.4% | 12,1 M € | +228% | 3,7 M € | -65.6% | 10,7 M € | +2.0% | 10,5 M € | +34.9% | 7,8 M € | +64.7% | 4,7 M € | +510% | 773,9 k € | +33.5% | 579,6 k € | -80.6% | 3 M € | +1031% | 264,1 k € |
| Debts | 5,8 M € | +8.2% | 5,4 M € | -78.1% | 24,6 M € | +47.8% | 16,7 M € | -10.2% | 18,5 M € | -20.8% | 23,4 M € | +54.3% | 15,2 M € | +176% | 5,5 M € | -10.5% | 6,1 M € | +33.7% | 4,6 M € | +49.0% | 3,1 M € | -29.4% | 4,4 M € | +75.3% | 2,5 M € | +976% | 231,5 k € |
| Other | |||||||||||||||||||||||||||
| Workforce | – | 6,1 ETP | -92.3% | 78,9 ETP | +13.5% | 69,5 ETP | +50.4% | 46,2 ETP | +20.6% | 38,3 ETP | +6.4% | 36,0 ETP | -0.6% | 36,2 ETP | -7.7% | 39,2 ETP | +4.3% | 37,6 ETP | +3.0% | 36,5 ETP | +128% | 16,0 ETP | +167% | 6,0 ETP | – | ||
Board of directors
Seen on filing of 31/12/2022 · 7 active · 80 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Ascend Performance Materials● Active | 0810.113.316 |
| 1012.379.397 | |
AUDANE INVEST● Active | 0816.921.429 |
BiocSol● Active | 1003.683.546 |
CEDRIC CLAERHOUDT● Active | 0477.799.927 |
Cellaïon● Liquidation | 0764.522.425 |
| 0859.906.087 | |
Cronos Sud● Active | 1014.190.824 |
DE SMET AGRO● Active | 0402.951.757 |
| 0438.987.752 | |
FLEXSO BRUSSELS● Active | 0898.889.892 |
Keiro● Active | 0681.490.821 |
NOVADIP BIOSCIENCES● Active | 0535.575.602 |
PARLYM BELGIUM● Active | 1028.144.372 |
PARSMET MANAGEMENT● Active | 1025.167.858 |
TFP IMMO● Active | 1032.940.330 |
The Akkermansia Company● Active | 0664.529.083 |
THE TORREFACTORY PROJECT● Active | 0679.686.720 |
Tools4Patient● Active | 0534.842.954 |
VAT Group Ascend● Active | 1002.911.308 |
Financials
Full financial information
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Consolidated accounts |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/07/2023 | 05/08/2022 | 23/06/2021 | 29/07/2020 | 03/06/2019 | 01/10/2018 |
| General meeting | 15/06/2023 | 06/07/2022 | 15/06/2021 | 03/07/2020 | 09/05/2019 | 01/01/9999 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
19 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2022 | 15/06/2023 | 07/07/2023 | French | |
| Abridged model | 31/12/2021 | 06/07/2022 | 05/08/2022 | French | |
| Abridged model | 31/12/2020 | 15/06/2021 | 23/06/2021 | French | |
| Abridged model | 31/12/2019 | 03/07/2020 | 29/07/2020 | French | |
| Abridged model | 31/12/2018 | 09/05/2019 | 03/06/2019 | French | |
| Consolidated accounts | 31/12/2018 | 01/01/9999 | 31/05/2019 | English | |
| Abridged model | 31/12/2017 | 17/05/2018 | 12/06/2018 | French | |
| Consolidated accounts | 31/12/2017 | 01/01/9999 | 01/10/2018 | English | |
| Abridged modelCorrection | 31/12/2016 | 11/05/2017 | 10/04/2018 | French | |
| Abridged model | 31/12/2016 | 11/05/2017 | 23/05/2017 | French | |
| Consolidated accounts | 31/12/2016 | 01/01/9999 | 18/07/2018 | English | |
| Abridged model | 31/12/2015 | 25/05/2016 | 11/08/2016 | French | |
| Abridged model | 31/12/2014 | 28/05/2015 | 08/06/2015 | French | |
| Abridged model | 31/12/2013 | 08/05/2014 | 13/05/2014 | French | |
| Abridged modelCorrection | 31/12/2012 | 15/05/2013 | 17/02/2014 | French | |
| Abridged model | 31/12/2012 | 15/05/2013 | 28/05/2013 | French | |
| Abridged model | 31/12/2011 | 10/05/2012 | 18/10/2012 | French | |
| Abridged model | 31/12/2010 | 31/05/2011 | 15/06/2011 | French | |
| Abridged model | 31/12/2009 | 17/05/2010 | 26/05/2010 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2022 · 7 active · 80 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates11/05/2022DEMISSIONS, NOMINATIONS
- Mandates23/02/2022DEMISSIONS, NOMINATIONS
- Restructuring09/02/2022RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Capital / shares23/02/2021OBJET - CAPITAL, ACTIONS
- Mandates10/11/2020DEMISSIONS, NOMINATIONS
- Mandates25/09/2020DEMISSIONS, NOMINATIONS
- Mandates02/09/2020CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates22/06/2020DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022-519,5 k €↓
- 2021Annual accounts 202116,5 M €↑
- 2020Annual accounts 2020-49 M €↓
- 2019Annual accounts 2019-30,3 M €↓
- 2018Annual accounts 2018-20,8 M €↓
- 2017Annual accounts 2017-12,2 M €↓
- 2016Annual accounts 2016-9,2 M €↓
- 2015Annual accounts 2015-6,7 M €↓
- 2014Annual accounts 2014-6,7 M €↓
- 2013Annual accounts 2013-6 M €↓
- 2012Annual accounts 2012-4,5 M €↓
- 2011Annual accounts 2011-3,5 M €↓
- 2010Annual accounts 2010-1,7 M €↓
- 2009Annual accounts 2009-551,3 k €
- 12/02/2009IncorporationPublic limited company